VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRD-A
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRD-ACrawford & Company
$11.72$577M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCRD-AQuarterly Financials

Crawford & Company (CRD-A) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Crawford & Company (CRD-A) quarterly income statement — complete revenue, gross profit & net income history

CRD-A Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue320.89M320.95M322.17M334.6M324.17M358.32M342.73M326.85M313.07M320.93M342.19M337.63M327.94M333.37M306.42M303.65M287.79M302.97M297.56M276.55M
Revenue Growth %-1.01%-10.43%-6%2.37%3.54%11.65%0.16%-3.19%-4.53%-3.73%11.67%11.19%13.95%10.03%2.98%9.8%9.78%14.07%13.72%13.86%
Medical Costs & Claims243.39M248.38M228.38M236.32M244.65M263.42M249.31M234.89M225.81M230.03M242.03M247.1M238.68M249.36M232.73M228.44M214.34M230.93M220.08M202.25M
Medical Cost Ratio %75.85%77.39%70.89%70.63%75.47%73.51%72.74%71.86%72.13%71.68%70.73%73.19%72.78%74.8%75.95%75.23%74.48%76.22%73.96%73.13%
Gross Profit77.5M72.57M93.79M98.27M79.52M94.9M93.42M91.96M87.27M90.9M100.15M90.53M89.26M84.01M73.69M75.21M73.44M72.04M77.48M74.3M
Gross Margin %24.15%22.61%29.11%29.37%24.53%26.49%27.26%28.14%27.87%28.32%29.27%26.81%27.22%25.2%24.05%24.77%25.52%23.78%26.04%26.87%
Gross Profit Growth %-2.54%-23.53%0.4%6.86%-8.88%4.4%-6.72%1.59%-2.23%8.2%35.91%20.36%21.53%16.62%-4.89%1.23%8.04%-0.04%1.87%4.92%
Operating Expenses64.77M58.67M71.8M80.75M63.14M71.09M74.02M74.72M77.32M86.64M76.64M72.67M66.71M62.53M62.98M65.4M64.84M66.73M60.76M58.66M
OpEx / Revenue %20.18%18.28%22.29%24.13%19.48%19.84%21.6%22.86%24.7%27%22.4%21.52%20.34%18.76%20.55%21.54%22.53%22.03%20.42%21.21%
Depreciation & Amortization9.59M10.5M10.08M9.81M9.65M9.24M8.81M8.85M9.3M8.39M9.11M9.19M9.05M8.72M8.92M9.36M9.1M9.41M9.83M10.46M
Combined Ratio %96.03%95.67%93.17%94.76%94.95%93.35%94.34%94.72%96.82%98.67%93.13%94.71%93.13%93.56%96.51%96.77%97.01%98.25%94.38%94.34%
Operating Income12.73M13.9M21.99M17.52M16.38M23.82M19.4M17.24M9.95M4.26M23.51M17.86M22.55M21.48M10.71M9.81M8.6M5.31M16.72M15.64M
Operating Margin %3.97%4.33%6.83%5.24%5.05%6.65%5.66%5.28%3.18%1.33%6.87%5.29%6.87%6.44%3.49%3.23%2.99%1.75%5.62%5.66%
Operating Income Growth %-22.28%-41.65%13.34%1.62%64.7%458.51%-17.48%-3.45%-55.89%-80.15%119.56%81.98%162.06%304.67%-35.97%-37.26%-7.27%-67.72%-30.31%2.17%
EBITDA22.32M24.39M32.07M27.34M26.03M33.05M28.21M26.09M19.24M12.65M32.63M27.05M31.59M30.2M19.63M19.17M17.7M14.72M26.55M26.11M
EBITDA Margin %6.96%7.6%9.96%8.17%8.03%9.22%8.23%7.98%6.15%3.94%9.53%8.01%9.63%9.06%6.41%6.31%6.15%4.86%8.92%9.44%
Interest Expense3.41M3.96M3.79M4.65M4.77M5.22M5.51M5.07M4.5M4.88M5.29M4.31M4.67M03.09M2.12M1.54M2.22M1.65M1.53M
Non-Operating Income2.04M16.43M0-796K2.39M9.02M-830K-817K1.62M539K-734K01.87M-34.73M36.15M-910K-517K-901K-902K-1.28M
Pretax Income7.29M-6.49M18.2M13.66M9.22M9.58M14.72M12.99M3.83M-1.15M18.95M13.55M16M17.4M-28.54M8.61M7.58M3.99M15.98M15.39M
Pretax Margin %2.27%-2.02%5.65%4.08%2.84%2.67%4.29%3.97%1.22%-0.36%5.54%4.01%4.88%5.22%-9.31%2.83%2.63%1.32%5.37%5.57%
Income Tax2.38M786K5.81M5.84M2.48M3.72M5.33M4.49M1.05M-161K6.78M5.21M5.27M31.67M-13.29M2.77M2.43M2.39M4.87M3.59M
Effective Tax Rate %32.59%-12.12%31.94%42.77%26.9%38.81%36.23%34.54%27.37%14%35.77%38.42%32.94%182.04%46.56%32.17%32%59.9%30.45%23.32%
Net Income4.91M-7.24M12.41M7.78M6.68M5.72M9.45M8.58M2.84M-818K12.32M8.43M10.68M-14.09M-15.14M5.83M5.1M1.65M11.2M11.78M
Net Margin %1.53%-2.26%3.85%2.33%2.06%1.6%2.76%2.63%0.91%-0.25%3.6%2.5%3.26%-4.23%-4.94%1.92%1.77%0.55%3.76%4.26%
Net Income Growth %-26.62%-226.53%31.26%-9.34%135.6%799.51%-23.26%1.86%-73.44%94.19%181.35%44.55%109.6%-952.21%-235.27%-50.51%-15.96%-82.41%-54.11%99.73%
EPS (Diluted)0.10-0.150.250.160.130.110.190.170.06-0.020.250.170.22-0.29-0.320.120.100.030.200.22
EPS Growth %-23.62%-236.36%31.58%-5.88%116.67%758.68%-24%0%-72.73%94.24%178.13%41.67%124.26%-1066.67%-260%-45.45%-10.82%-83.33%-56.52%100%
EPS (Basic)0.10-0.150.250.160.140.120.190.170.06-0.020.250.170.22-0.29-0.320.120.100.030.210.22
Diluted Shares Outstanding49.4M50.07M50.07M49.96M49.86M49.86M49.55M49.55M49.82M48.87M49.9M49.62M48.55M48.58M48.4M49.13M51.95M52.89M54.36M54.44M